Contact this trialFirst, we need to learn more about you.
Behavioural Intervention
Difelikefalin for Itching
Recruiting0 awardsPhase 2 & 3
Metairie, Louisiana
This trial is testing a new oral medication called difelikefalin to see if it can help adults who suffer from severe itching. The medication works by blocking the signals that cause itching. The study will compare different doses to find the most effective one and ensure it is safe for long-term use. Difelikefalin was first approved in the USA for treating severe itching in adults undergoing hemodialysis.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service